Nivolumab-associated bullous pemphigoid reactions involving multiple epitopes

Eur J Dermatol. 2019 Oct 1;29(5):552-554. doi: 10.1684/ejd.2019.3619.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents, Immunological / adverse effects*
  • Female
  • Humans
  • Lymphatic Metastasis / drug therapy
  • Melanoma / drug therapy
  • Melanoma / pathology
  • Melanoma / secondary
  • Nivolumab / adverse effects*
  • Pemphigoid, Bullous / chemically induced*
  • Pemphigoid, Bullous / pathology
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab